Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Announcement regarding the governance of Renault Group
-
Resecurity Expands LATAM Presence Through Strategic Partnership with INFORC in Ecuador
-
DMRC IMPORTANT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Digimarc Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DM
-
InterLink Labs Surpasses 1 Million Registered Users and Confirms Strategic Investment from Google
-
Lux MedSpa Brickell Launches New Custom Facial Page
-
CODI IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Compass Diversified Holdings Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Cla
-
NDP MPP Jessica Bell to Join WSIB Strike Picket Line in Toronto
-
CGTN: From father to son: The enduring values guiding Xi Jinping
-
ZBIO DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Cl
-
BAIC Group Showcases Eight International Models at the 2025 International Automotive & Supply Chain Expo (Hong Kong)
-
Future of Uncrewed Airpower on Display at Paris Air Show
-
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-
-
Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-
-
NSSC DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages NAPCO Security Technologies, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 24 Deadlin
-
Freedom Holding Corp. Reports Fiscal Year 2025 Financial Results
-
ROSEN, A LEADING LAW FIRM, Encourages SelectQuote, Inc. Investors to Inquire About Securities Class Action Investigation - SLQT
-
Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clini
-
Black Book Research Names 18 European Healthcare IT Startups to Watch at HLTH Europe 2025
-
Livecaller Presents the First Free iOS Native App to Help iPhone Users Say Hello to Real-Time Caller ID
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ELV
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NWTN Inc. - NWTN
-
Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers – PEPG
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Red Cat Holdings, Inc. and Certain Officers – RCAT
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE
-
Pomerantz Law Firm Announces the Filing of a Class Action Against MicroStrategy Incorporated d/b/a Strategy and Certain Officers – MSTR
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers – BITF
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Civitas Resources, Inc. and Certain Officers – CIVI
-
Scatec reaches financial close for the 1.1GW solar + 100MW/200MWh BESS Obelisk project
-
Scatec signs PPA for 900MW onshore wind project in Egypt
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Avis Budget Group, Inc. and Certain Officers – CAR
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vestis Corporation of Class Action Lawsuit and Upcoming Deadlines - VSTS
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Petco Health and Wellness Company, Inc. - WOOF
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Take-Two Interactive Software, Inc. - TTWO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apple Inc. - AAPL
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADTRAN Holdings, Inc. - ADTN
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Luminar Technologies, Inc. - LAZR
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flowco Holdings Inc. - FLOC
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation - DDD
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meta Platforms, Inc. - META
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metallus Inc. - MTUS
